The page is the record's research on the issuer — no analyst, no rating, no view.

# HALOZYME THERAPEUTICS, INC. (NASDAQ: HALO) — research page

As of 2026-11-08 · us-cm-kg · record version 1

## Identity and listing

The issuer is HALOZYME THERAPEUTICS, INC., listed on NASDAQ under ticker HALO, ISIN US40637H1095, LEI 529900242I3SV9AGM753. Its security type is Corporate. Its segment is not on the record. Its sector is 2836 Biological Products, (No Diagnostic Substances), and its jurisdiction is United States — Delaware. Its listing status is listed, not halted.

## The disclosure read

The record holds 97 filings across 57 filing days in the twelve months to 2026-11-08. The median gap between filing days is 5.5 days. The latest filing is dated 2026-11-05, three days before the record date, and is of type results. By type, the record holds 56 directors_dealings, 16 regulatory_filing, 9 results, 8 director_change, 4 corporate_news, 3 agm_egm and 1 ad_hoc. For NASDAQ the median cadence gap is 6.0 days across 4,359 issuers, with a median of 52 filings and a median latency of 5.0 days. For the sector the median cadence gap is 5.5 days across 176 issuers, with a median of 65.5 filings and a median latency of 4.0 days.

## Auditor

The auditor of record is Ernst & Young LLP, located in San Diego, California. The record holds no auditor changes.

## Events and halts

The record holds no listing, delisting, name change or segment move lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag reads listed, not halted.

## Orderability

The outcome is not determinable. The chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

## Coverage

No research houses were found on the issuer's own investor-relations page.

## Open research

No openly published research notes were found on the record.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The vintage is sealed. Sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)
- https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin)
- https://data.sec.gov/submissions/CIK0001159036.json (identity.jurisdiction)
- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)
- https://mcp.us-cm-kg.ai/events/NASDAQ/HALO (the disclosure lines)
- https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)
- https://www.sec.gov/Archives/edgar/data/1159036/000115903626000024/halo-20251231.htm (the auditor)
- https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)
- https://mcp.us-cm-kg.ai/record/NASDAQ/HALO (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/HALO · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp